Diabetes leader DeFronzo receives $250,000 Hamm Prize

February 16, 2017

Ralph DeFronzo, M.D., professor of medicine and chief of diabetes in the Long School of Medicine at UT Health San Antonio, has been selected to receive the 2017 Harold Hamm International Prize for Biomedical Research in Diabetes, which includes $250,000. Dr. DeFronzo is the author of 750 publications and has contributed innovative ideas defining the […]

diabetes in men

Diabetes in Control: Effectiveness of A GLP-1 Receptor Agonist Plus A TZD for Type 2 Diabetes

February 16, 2017

The study was done to examine the efficacy and safety of combination therapy with the GLP-1 receptor agonist exenatide plus the TZD pioglitazone versus basal-bolus insulin in poorly controlled type 2 diabetic patients with very high HbA1c (HbA1c>10%) on metformin plus sulfonylurea and long duration of disease. Read the full story at Diabetes in Control